Astrazeneca Lp Drug Patent Portfolio
Astrazeneca Lp owns 1 orange book drug protected by 16 US patents Given below is the list of Astrazeneca Lp's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6428810 | Pharmaceutical formulation comprising omeprazole | 03 May, 2020 | Expired |
| US6428810 | Pharmaceutical formulation comprising omeprazole | 03 Nov, 2019 | Expired |
| US6369085 | Form of S-omeprazole | 25 Nov, 2018 | Expired |
| US7411070 | Form of S-omeprazole | 25 Nov, 2018 | Expired |
| US6369085 | Form of S-omeprazole | 25 May, 2018 | Expired |
| US7411070 | Form of S-omeprazole | 25 May, 2018 | Expired |
| US5900424 | Omeprazole magnesium salt form | 04 Nov, 2016 | Expired |
| US5900424 | Omeprazole magnesium salt form | 04 May, 2016 | Expired |
| US5714504 | Compositions | 03 Aug, 2015 | Expired |
| US5690960 | Pharmaceutical formulation of omeprazole | 25 May, 2015 | Expired |
| US5714504 | Compositions | 03 Feb, 2015 | Expired |
| US5877192 | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole | 27 Nov, 2014 | Expired |
| US6875872 | Compounds | 27 Nov, 2014 | Expired |
| US5690960 | Pharmaceutical formulation of omeprazole | 25 Nov, 2014 | Expired |
| US5877192 | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole | 27 May, 2014 | Expired |
| US6875872 | Compounds | 27 May, 2014 | Expired |
Latest Legal Activities on Astrazeneca Lp's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Astrazeneca Lp.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 14 Sep, 2020 | US7411070 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 30 Mar, 2020 | US7411070 (Litigated) |
|
Patent Issue Date Used in PTA Calculation
Critical
| 12 Aug, 2008 | US7411070 (Litigated) |
|
Recordation of Patent Grant Mailed
Critical
| 12 Aug, 2008 | US7411070 (Litigated) |
|
Issue Notification Mailed
Critical
| 23 Jul, 2008 | US7411070 (Litigated) |
| Printer Rush- No mailing | 17 Jul, 2008 | US7411070 (Litigated) |
| Dispatch to FDC | 17 Jul, 2008 | US7411070 (Litigated) |
|
Application Is Considered Ready for Issue
Critical
| 17 Jul, 2008 | US7411070 (Litigated) |
|
Pubs Case Remand to TC
Critical
| 16 Jul, 2008 | US7411070 (Litigated) |
| Printer Rush- No mailing | 30 Jun, 2008 | US7411070 (Litigated) |
|
Pubs Case Remand to TC
Critical
| 15 Apr, 2008 | US7411070 (Litigated) |
| Mail Miscellaneous Communication to Applicant | 17 Mar, 2008 | US7411070 (Litigated) |
| Miscellaneous Communication to Applicant - No Action Count | 10 Mar, 2008 | US7411070 (Litigated) |
|
Issue Fee Payment Received
Critical
| 06 Mar, 2008 | US7411070 (Litigated) |
|
Issue Fee Payment Verified
Critical
| 06 Mar, 2008 | US7411070 (Litigated) |
Astrazeneca Lp's Family Patents
Astrazeneca Lp Drug List
Given below is the complete list of Astrazeneca Lp's drugs and the patents protecting them.
1. Nexium 24hr
Nexium 24hr is protected by 18 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6428810
(Pediatric)
| Pharmaceutical formulation comprising omeprazole |
03 May, 2020
(4 years ago)
| Expired |
| US6428810 | Pharmaceutical formulation comprising omeprazole |
03 Nov, 2019
(5 years ago)
| Expired |
| US6369085
(Pediatric)
| Form of S-omeprazole |
25 Nov, 2018
(5 years ago)
| Expired |
| US7411070
(Pediatric)
| Form of S-omeprazole |
25 Nov, 2018
(5 years ago)
| Expired |
| US7411070
(Pediatric)
| Form of S-omeprazole |
18 Nov, 2018
(6 years ago)
| Expired |
| US6369085 | Form of S-omeprazole |
25 May, 2018
(6 years ago)
| Expired |
| US7411070 | Form of S-omeprazole |
25 May, 2018
(6 years ago)
| Expired |
| US7411070 | Form of S-omeprazole |
18 May, 2018
(6 years ago)
| Expired |
| US5900424
(Pediatric)
| Omeprazole magnesium salt form |
04 Nov, 2016
(8 years ago)
| Expired |
| US5900424 | Omeprazole magnesium salt form |
04 May, 2016
(8 years ago)
| Expired |
| US5714504
(Pediatric)
| Compositions |
03 Aug, 2015
(9 years ago)
| Expired |
| US5690960
(Pediatric)
| Pharmaceutical formulation of omeprazole |
25 May, 2015
(9 years ago)
| Expired |
| US5714504 | Compositions |
03 Feb, 2015
(9 years ago)
| Expired |
| US5877192
(Pediatric)
| Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole |
27 Nov, 2014
(9 years ago)
| Expired |
| US6875872
(Pediatric)
| Compounds |
27 Nov, 2014
(9 years ago)
| Expired |
| US5690960 | Pharmaceutical formulation of omeprazole |
25 Nov, 2014
(9 years ago)
| Expired |
| US5877192 | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole |
27 May, 2014
(10 years ago)
| Expired |
| US6875872 | Compounds |
27 May, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nexium 24hr's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List